Arecor Proprietary Pipeline

Using our Arestat™ technology platform, we are developing enhanced medicines for the treatment of diabetes and other chronic conditions

Tetris Pharma Portfolio

Our specialty pharmaceutical experts in registering, marketing, sales and the distribution of commercial-stage speciality hospital products across the UK and Europe

Our Partners

We partner with leading pharmaceutical and biotechnology companies through technology partnerships to enhance their proprietary products across a range of indications and stages of development

Latest News and Events

  • 18th November 2024

    APPOINTMENT OF INTERIM CHIEF FINANCIAL OFFICER

  • 11th September 2024

    ARECOR PRESENTS POSITIVE DATA FROM PHASE I CLINICAL TRIAL OF AT278 IN LATE-BREAKING ORAL PRESENTATION AT EASD 2024

  • 3rd September 2024

    ARECOR ANNOUNCES ORAL PRESENTATION OF POSITIVE AT278 PHASE 1 CLINICAL DATA AT THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES 2024